Real-World Clinical Outcomes of Ujvira® (Trastuzumab Emtansine Biosimilar) in HER2-Positive Breast Cancer: A Retrospective Observational Study in Indian Patients. Journal of Cancer Research Updates, [S. l.], v. 14, p. 114–120, 2025. DOI: 10.30683/1929-2279.2025.14.13. Disponível em: https://www.neoplasiaresearch.com/index.php/jcru/article/view/854. Acesso em: 6 may. 2026.